Escherichia coli and Proteus mirabilis Inhibit the Perinuclear But Not the Circulating Antineutrophil Cytoplasmic Antibody Reaction

REFERENCES

• Asherson GL, Holborow EJ. Autoantibody production in rabbits. VII. Autoantibodies to gut produced by the injection of bacteria. Immunology 1966;10:161–7.
   Google Scholar
• Perlmann P, Hammarstrom S, Lagercrantz R, Campbell D. Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli 0:14 antigen. Proc Soc Exp Biol Med 1967;125:975–80.
   PubMed Web of Science ®Google Scholar
• Mary Cooke E, Ewins SP, Hywel-Jones J, Lennard-Jones JE. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut 1974;15:143–6.
   Google Scholar
• Burke DA, Axon ATR, Clayden SA, Dixon MF, Johnston D, Lacey RW. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990;4:123–9.
   PubMed Web of Science ®Google Scholar
• Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:202–10.
   Google Scholar
• Rump JA, Schölmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease. Immunobiology 1990;181:406–13.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590–6.
   Google Scholar
• Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33: 668–74.
   PubMed Web of Science ®Google Scholar
• Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657–62.
   Google Scholar
• Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Gastroenterol Clin Biol 1992;16:656–60.
   Google Scholar
• Yang P, Bohr J, Tysk C, Danielsson D, Järnerot G. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease and collagenous colitis: no association with lactoferrin, β-glucuronidase, myeloperoxidase, or proteinase 3. Inflamm Bowel Dis 1996;2: 173–7.
   Google Scholar
• Boerr LA, Sambuelli AM, Katz S, Solé L, Gil A, Gonqalves S, et al. Clinical heterogeneity of ulcerative colitis in relation to frequency of pANCA reactivity [abstract]. Gastroenterology 1995;108:A785.
   Google Scholar
• Broekroelofs J, Mulder AHL, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci 1994;39:545–9.
   PubMed Web of Science ®Google Scholar
• Lindgren S, Florén CH, Lindhagen T, Starck M, Stewenius J, Nassberger L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur J Gastroenterol Hepatol 1995;7:563–8.
   PubMed Web of Science ®Google Scholar
• Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994;55:34–9.
   PubMed Web of Science ®Google Scholar
• Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson Å. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol 1995;30:693–8.
   Google Scholar
• Nässberger L, Ljungh A, Schumacher G, Kollberg B. β-Glucuronidase antibodies in ulcerative colitis [letter]. Lancet 1992;340: 734–5.
   Google Scholar
• Peen E, Almer S, Bodemar G, Rydén B-O, Sjölin C, Tejle K, et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn’s disease. Gut 1993;34:56–62.
   Google Scholar
• Kaneko K, Suzuki Y, Yamashiro Y, Yabuta K. Is p-ANCA in ulcerative colitis directed against β-glucuronidase? [letter]. Lancet 1993;341:320–3.
   PubMedGoogle Scholar
• Sung JY, Chan KL, Hsu R, Liew CT, Lawton JWM. Ulcerative colitis and antineutrophil cytoplasmic antibodies in Hong Kong Chinese. Am J Gastroenterol 1993;88:864–9.
   Google Scholar
• Deusch K, Oberstadt K, Schaedel W, Weber M, Classen M. P-ANCA as a diagnostic marker in ulcerative colitis. Adv Exp Med Biol 1993;336:527–31.
   PubMedGoogle Scholar
• Halbwachs-Mecarelli L, Nusbaum P, Noël LH, Reumaux D, Erlinger S, Grünfeld JP, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn’s disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79–84.
   Google Scholar
• Ellerbroek DM, Qudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BME, von dem Borne AEG Kr, et al. Neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis. J Clin Pathol 1994;47:257–62.
   Google Scholar
• Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994;95:490–7.
   PubMed Web of Science ®Google Scholar
• Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgsen HJ. Antigen specificity of circulating anti-neutrophil cytoplasmatic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:783–9.
   Google Scholar
• Tysk C, Järnerot G. Ulcerative proctocolitis in (Örebro, Sweden. A retrospective epidemiologic study, 1963–1987. Scand J Gastroenterol 1992;27: 945–50.
   Google Scholar
• Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specficity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651–7.
   PubMed Web of Science ®Google Scholar
• Yang P, Jarnerot G, Danielsson D, Tysk C, Lindberg E. P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995;36:887–90.
   Google Scholar
• Bøyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens 1974;4:269–74.
   PubMed Web of Science ®Google Scholar
• Yang P. Comparative evaluation of unfixed and fixed human neutrophils for determination of anti-neutrophil cytoplasmic antibodies by indirect immunofluorescence. J Clin Pathol 1997; 50:677–80.
   PubMedGoogle Scholar
• Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S, et al. Nuclear localization of the antigen detected by ulcerative colitisassociated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995;147:979–87.
   PubMedGoogle Scholar
• Vidrich A, Lee J, James E, Cobb L, Targan S. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 1995;15: 293–9.
   Google Scholar